Comparative effectiveness of home blood pressure telemonitoring (HBPTM) plus nurse case management versus HBPTM alone among Black and Hispanic stroke survivors: study protocol for a randomized controlled trial

Tanya M Spruill, Olajide Williams, Jeanne A Teresi, Susan Lehrer, Liliana Pezzin, Salina P Waddy, Ronald M Lazar, Stephen K Williams, Girardin Jean-Louis, Joseph Ravenell, Sunil Penesetti, Albert Favate, Judith Flores, Katherine A Henry, Anne Kleiman, Steven R Levine, Richard Sinert, Teresa Y Smith, Michelle Stern, Helen Valsamis, Gbenga Ogedegbe, Tanya M Spruill, Olajide Williams, Jeanne A Teresi, Susan Lehrer, Liliana Pezzin, Salina P Waddy, Ronald M Lazar, Stephen K Williams, Girardin Jean-Louis, Joseph Ravenell, Sunil Penesetti, Albert Favate, Judith Flores, Katherine A Henry, Anne Kleiman, Steven R Levine, Richard Sinert, Teresa Y Smith, Michelle Stern, Helen Valsamis, Gbenga Ogedegbe

Abstract

Background: Black and Hispanic stroke survivors experience higher rates of recurrent stroke than whites. This disparity is partly explained by disproportionately higher rates of uncontrolled hypertension in these populations. Home blood pressure telemonitoring (HBPTM) and nurse case management (NCM) have proven efficacy in addressing the multilevel barriers to blood pressure (BP) control and reducing BP. However, the effectiveness of these interventions has not been evaluated in stroke patients. This study is designed to evaluate the comparative effectiveness, cost-effectiveness and sustainability of these two telehealth interventions in reducing BP and recurrent stroke among high-risk Black and Hispanic stroke survivors with uncontrolled hypertension.

Methods/design: A total of 450 Black and Hispanic patients with recent nondisabling stroke and uncontrolled hypertension are randomly assigned to one of two 12-month interventions: 1) HBPTM with wireless feedback to primary care providers or 2) HBPTM plus individualized, culturally-tailored, telephone-based NCM. Patients are recruited from stroke centers and primary care practices within the Health and Hospital Corporations (HHC) Network in New York City. Study visits occur at baseline, 6, 12 and 24 months. The primary outcomes are within-patient change in systolic BP at 12 months, and the rate of stroke recurrence at 24 months. The secondary outcome is the comparative cost-effectiveness of the interventions at 12 and 24 months; and exploratory outcomes include changes in stroke risk factors, health behaviors and treatment intensification. Recruitment for the stroke telemonitoring hypertension trial is currently ongoing.

Discussion: The combination of two established and effective interventions along with the utilization of health information technology supports the sustainability of the HBPTM + NCM intervention and feasibility of its widespread implementation. Results of this trial will provide strong empirical evidence to inform clinical guidelines for management of stroke in minority stroke survivors with uncontrolled hypertension. If effective among Black and Hispanic stroke survivors, these interventions have the potential to substantially mitigate racial and ethnic disparities in stroke recurrence.

Trial registration: ClinicalTrials.gov NCT02011685 . Registered 10 December 2013.

Figures

Figure 1
Figure 1
Study design.

References

    1. Lackland DT, Roccella EJ, Deutsch AF, Fornage M, George MG, Howard G, et al. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke. 2014;45:315–53. doi: 10.1161/.
    1. Morgenstern LB, Smith MA, Lisabeth LD, Risser JM, Uchino K, Garcia N, et al. Excess stroke in Mexican Americans compared with non-Hispanic Whites: the Brain Attack Surveillance in Corpus Christi Project. Am J Epidemiol. 2004;160:376–83. doi: 10.1093/aje/kwh225.
    1. Lisabeth LD, Smith MA, Brown DL, Moye LA, Risser JM, Morgenstern LB. Ethnic differences in stroke recurrence. Ann Neurol. 2006;60:469–75. doi: 10.1002/ana.20943.
    1. Ottenbacher KJ, Campbell J, Kuo YF, Deutsch A, Ostir GV, Granger CV. Racial and ethnic differences in postacute rehabilitation outcomes after stroke in the United States. Stroke. 2008;39:1514–9. doi: 10.1161/STROKEAHA.107.501254.
    1. Broderick J, Brott T, Kothari R, Miller R, Khoury J, Pancioli A, et al. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke. 1998;29:415–21. doi: 10.1161/01.STR.29.2.415.
    1. Feng W, Hendry RM, Adams RJ. Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients. Neurology. 2010;74:588–93. doi: 10.1212/WNL.0b013e3181cff776.
    1. Kennedy BS. Does race predict stroke readmission? An analysis using the truncated negative binomial model. J Natl Med Assoc. 2005;97:699–713.
    1. Sheinart KF, Tuhrim S, Horowitz DR, Weinberger J, Goldman M, Godbold JH. Stroke recurrence is more frequent in Blacks and Hispanics. Neuroepidemiology. 1998;17:188–98. doi: 10.1159/000026172.
    1. Cushman M, Cantrell RA, McClure LA, Howard G, Prineas RJ, Moy CS, et al. Estimated 10-year stroke risk by region and race in the United States: geographic and racial differences in stroke risk. Ann Neurol. 2008;64:507–13. doi: 10.1002/ana.21493.
    1. Boden-Albala B, Sacco RL, Lee HS, Grahame-Clarke C, Rundek T, Elkind MV, et al. Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke. 2008;39:30–5. doi: 10.1161/STROKEAHA.107.496588.
    1. Thomas AJ, Eberly LE, Davey Smith G, Neaton JD, Stamler J. Race/ethnicity, income, major risk factors, and cardiovascular disease mortality. Am J Public Health. 2005;95:1417–23. doi: 10.2105/AJPH.2004.048165.
    1. Morgenstern LB, Steffen-Batey L, Smith MA, Moye LA. Barriers to acute stroke therapy and stroke prevention in Mexican Americans. Stroke. 2001;32:1360–4. doi: 10.1161/01.STR.32.6.1360.
    1. Bravata DM, Wells CK, Gulanski B, Kernan WN, Brass LM, Long J, et al. Racial disparities in stroke risk factors: the impact of socioeconomic status. Stroke. 2005;36:1507–11. doi: 10.1161/01.STR.0000170991.63594.b6.
    1. McGruder HF, Malarcher AM, Antoine TL, Greenlund KJ, Croft JB. Racial and ethnic disparities in cardiovascular risk factors among stroke survivors: United States 1999 to 2001. Stroke. 2004;35:1557–61. doi: 10.1161/01.STR.0000130427.84114.50.
    1. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37:577–617. doi: 10.1161/01.STR.0000199147.30016.74.
    1. Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke. 2004;35:1024. doi: 10.1161/01.STR.0000116869.64771.5A.
    1. Howard G, Lackland DT, Kleindorfer DO, Kissela BM, Moy CS, Judd SE, et al. Racial differences in the impact of elevated systolic blood pressure on stroke risk. JAMA Intern Med. 2013;173:46–51. doi: 10.1001/2013.jamainternmed.857.
    1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–52. doi: 10.1161/01.HYP.0000107251.49515.c2.
    1. Weber MA. Strategies for improving blood pressure control. Am J Hypertens. 1998;11:897–9. doi: 10.1016/S0895-7061(98)00081-8.
    1. Hill MN, Sutton BS. Barriers to hypertension care and control. Curr Hypertens Rep. 2000;2:445–50. doi: 10.1007/s11906-000-0026-y.
    1. Alderman MH. Barriers to blood pressure control. Am J Hypertens. 1999; 12(12 Pt 1–2):1268–9.
    1. Khan NA, Yun L, Humphries K, Kapral M. Antihypertensive drug use and adherence after stroke: are there sex differences? Stroke. 2010;41:1445–9. doi: 10.1161/STROKEAHA.110.579375.
    1. Muntner P, Halanych JH, Reynolds K, Durant R, Vupputuri S, Sung VW, et al. Low medication adherence and the incidence of stroke symptoms among individuals with hypertension: the REGARDS study. J Clin Hypertens. 2011;13:479–86. doi: 10.1111/j.1751-7176.2011.00464.x.
    1. Adams AS, Uratsu C, Dyer W, Magid D, O’Connor P, Beck A, et al. Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users. JAMA Intern Med. 2013;173:54–61. doi: 10.1001/2013.jamainternmed.955.
    1. Mehta SS, Wilcox CS, Schulman KA. Treatment of hypertension in patients with comorbidities: results from the study of hypertensive prescribing practices (SHyPP) Am J Hypertens. 1999;12(4 Pt 1):333–40.
    1. Tuhrim S, Cooperman A, Rojas M, Brust JC, Koppel B, Martin K, et al. The association of race and sex with the underuse of stroke prevention measures. J Stroke Cerebrovasc Dis. 2008;17:226–34. doi: 10.1016/j.jstrokecerebrovasdis.2008.02.003.
    1. Ballard DJ, Strogatz DS, Wagner EH, Siscovick DS, James SA, Kleinbaum DG, et al. Hypertension control in a rural southern community: medical care process and dropping out. Am J Prev Med. 1988;4:133–9.
    1. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957–63. doi: 10.1056/NEJM199812313392701.
    1. Hyman DJ, Pavlik VN, Vallbona C. Physician role in lack of awareness and control of hypertension. J Clin Hypertens. 2000;2:324–30.
    1. Cruz-Flores S, Rabinstein A, Biller J, Elkind MS, Griffith P, Gorelick PB, et al. Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2091–116. doi: 10.1161/STR.0b013e3182213e24.
    1. Levine DA, Neidecker MV, Kiefe CI, Karve S, Williams LS, Allison JJ. Racial/ethnic disparities in access to physician care and medications among US stroke survivors. Neurology. 2011;76:53–61. doi: 10.1212/WNL.0b013e318203e952.
    1. Ogedegbe G. Barriers to optimal hypertension control. J Clin Hypertens. 2008;10:644–6. doi: 10.1111/j.1751-7176.2008.08329.x.
    1. Handler J, Lackland DT. Translation of hypertension treatment guidelines into practice: a review of implementation. J Am Soc Hypertens. 2011;5:197–207. doi: 10.1016/j.jash.2011.03.002.
    1. Bray EP, Holder R, Mant J, McManus RJ. Does self-monitoring reduce blood pressure? Meta-analysis with meta-regression of randomized controlled trials. Ann Med. 2010;42:371–86. doi: 10.3109/07853890.2010.489567.
    1. Cappuccio FP, Kerry SM, Forbes L, Donald A. Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ. 2004;329:145. doi: 10.1136/.
    1. Agarwal R, Bills JE, Hecht TJ, Light RP. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension. 2011;57:29–38. doi: 10.1161/HYPERTENSIONAHA.110.160911.
    1. Bosworth HB, Olsen MK, Gentry P, Orr M, Dudley T, McCant F, et al. Nurse administered telephone intervention for blood pressure control: a patient-tailored multifactorial intervention. Patient Educ Couns. 2005;57:5–14. doi: 10.1016/j.pec.2004.03.011.
    1. Bosworth HB, Olsen MK, Neary A, Orr M, Grubber J, Svetkey L, et al. Take Control of Your Blood Pressure (TCYB) study: a multifactorial tailored behavioral and educational intervention for achieving blood pressure control. Patient Educ Couns. 2008;70:338–47. doi: 10.1016/j.pec.2007.11.014.
    1. Gabbay RA, Lendel I, Saleem TM, Shaeffer G, Adelman AM, Mauger DT, et al. Nurse case management improves blood pressure, emotional distress and diabetes complication screening. Diabetes Res Clin Pract. 2006;71:28–35. doi: 10.1016/j.diabres.2005.05.002.
    1. Bosworth HB, Olsen MK, McCant F, Harrelson M, Gentry P, Rose C, et al. Hypertension Intervention Nurse Telemedicine Study (HINTS): testing a multifactorial tailored behavioral/educational and a medication management intervention for blood pressure control. Am Heart J. 2007;153:918–24. doi: 10.1016/j.ahj.2007.03.004.
    1. Stamp KD, Allen NA, Lehrer S, Zagarins SE, Welch G. Telehealth program for Medicaid patients with type 2 diabetes lowers hemoglobin A1c. J Manag Care Med. 2012;15:39–46.
    1. Bosworth HB, Olsen MK, Grubber JM, Neary AM, Orr MM, Powers BJ, et al. Two self-management interventions to improve hypertension control: a randomized trial. Ann Intern Med. 2009;151:687–95. doi: 10.7326/0000605-200911170-00148.
    1. Artinian NT, Flack JM, Nordstrom CK, Hockman EM, Washington OG, Jen KL, et al. Effects of nurse-managed telemonitoring on blood pressure at 12-month follow-up among urban African Americans. Nurs Res. 2007;56:312–22. doi: 10.1097/01.NNR.0000289501.45284.6e.
    1. Wilson JT, Hareendran A, Grant M, Baird T, Schulz UG, Muir KW, et al. Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin Scale. Stroke. 2002;33:2243–6. doi: 10.1161/.
    1. Golden RR, Teresi JA, Gurland BJ. Development of indicator scales for the Comprehensive Assessment and Referral Evaluation (CARE) interview schedule. J Gerontol. 1984;39:138–46. doi: 10.1093/geronj/39.2.138.
    1. Teresi JA, Golden RR, Gurland BJ. Concurrent and predictive validity of indicator scales developed for the Comprehensive Assessment and Referral Evaluation interview schedule. J Gerontol. 1984;39:158–65. doi: 10.1093/geronj/39.2.158.
    1. Teresi JA, Golden RR, Gurland BJ, Wilder DE, Bennett RG. Construct validity of indicator-scales developed from the Comprehensive Assessment and Referral Evaluation interview schedule. J Gerontol. 1984;39:147–57. doi: 10.1093/geronj/39.2.147.
    1. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111:697–716. doi: 10.1161/01.CIR.0000154900.76284.F6.
    1. Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med. 2007;167:141–7. doi: 10.1001/archinte.167.2.141.
    1. Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ, et al. The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology. 2005;25:135–43. doi: 10.1159/000086678.
    1. Saver JL, Warach S, Janis S, Odenkirchen J, Becker K, Benavente O, et al. Standardizing the structure of stroke clinical and epidemiologic research data: the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element (CDE) project. Stroke. 2012;43:967–73. doi: 10.1161/STROKEAHA.111.634352.
    1. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83. doi: 10.1016/0021-9681(87)90171-8.
    1. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55:1621–6. doi: 10.1212/WNL.55.11.1621.
    1. Pilkonis PA, Choi SW, Reise SP, Stover AM, Riley WT, Cella D, et al. Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS(R)): depression, anxiety, and anger. Assessment. 2011;18:263–83. doi: 10.1177/1073191111411667.
    1. Mahoney FI, Wood OH, Barthel DW. Rehabilitation of chronically ill patients: the influence of complications on the final goal. South Med J. 1958;51:605–9. doi: 10.1097/00007611-195805000-00011.
    1. The EuroQol Group EuroQol–a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208. doi: 10.1016/0168-8510(90)90421-9.
    1. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10:348–54. doi: 10.1111/j.1751-7176.2008.07572.x.
    1. Thompson FE, Midthune D, Subar AF, Kipnis V, Kahle LL, Schatzkin A. Development and evaluation of a short instrument to estimate usual dietary intake of percentage energy from fat. J Am Diet Assoc. 2007;107:760–7. doi: 10.1016/j.jada.2007.02.006.
    1. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–95. doi: 10.1249/01.MSS.0000078924.61453.FB.
    1. Shea S, Weinstock RS, Teresi JA, Palmas W, Starren J, Cimino JJ, et al. A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus: 5 year results of the IDEATel study. J Am Med Inform Assoc. 2009;16:446–56. doi: 10.1197/jamia.M3157.
    1. Green BB, Cook AJ, Ralston JD, Fishman PA, Catz SL, Carlson J, et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008;299:2857–67. doi: 10.1001/jama.299.24.2857.
    1. McManus RJ, Mant J, Bray EP, Holder R, Jones MI, Greenfield S, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet. 2010;376:163–72. doi: 10.1016/S0140-6736(10)60964-6.
    1. Cohen J. Statistical power analysis for the behavioral sciences. New York: Academic; 1988.
    1. Diggle PL, Liang K-Y, Zeger SL. Analysis of longitudinal data. New York: Oxford University Press; 1994.
    1. Liu G, Liang KY. Sample size calculations for studies with correlated observations. Biometrics. 1997;53:937–47. doi: 10.2307/2533554.
    1. Fleiss J. Design and analysis of clinical experiments. New York: John Wiley and Sons; 1999.
    1. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365:993–1003. doi: 10.1056/NEJMoa1105335.
    1. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine: panel on cost-effectiveness in health and medicine. JAMA. 1996;276:1172–7. doi: 10.1001/jama.1996.03540140060028.
    1. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA. 1996;276:1253–8. doi: 10.1001/jama.1996.03540150055031.
    1. Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses: panel on cost-effectiveness in health and medicine. JAMA. 1996;276:1339–41. doi: 10.1001/jama.1996.03540160061034.
    1. Kraemer HC, Wilson GT, Fairburn CG, Agras WS. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry. 2002;59:877–83. doi: 10.1001/archpsyc.59.10.877.
    1. Pincus T, Miles C, Froud R, Underwood M, Carnes D, Taylor SJ. Methodological criteria for the assessment of moderators in systematic reviews of randomised controlled trials: a consensus study. BMC Med Res Methodol. 2011;11:14. doi: 10.1186/1471-2288-11-14.
    1. Wang R, Ware JH. Detecting moderator effects using subgroup analyses. Prev Sci. 2011;14:111–20. doi: 10.1007/s11121-011-0221-x.
    1. Clark CE, Smith LF, Taylor RS, Campbell JL. Nurse led interventions to improve control of blood pressure in people with hypertension: systematic review and meta-analysis. BMJ. 2010;341:c3995. doi: 10.1136/bmj.c3995.
    1. Clark CE, Smith LF, Taylor RS, Campbell JL. Nurse-led interventions used to improve control of high blood pressure in people with diabetes: a systematic review and meta-analysis. Diabet Med. 2011;28:250–61.
    1. Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T. Self-monitoring and other non-pharmacological interventions to improve the management of hypertension in primary care: a systematic review. Br J Gen Pract. 2010;60:e476–88. doi: 10.3399/bjgp10X544113.
    1. Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev. 2010;3:CD005182.
    1. Kleindorfer DO, Khoury J, Moomaw CJ, Alwell K, Woo D, Flaherty ML, et al. Stroke incidence is decreasing in whites but not in blacks: a population-based estimate of temporal trends in stroke incidence from the Greater Cincinnati/Northern Kentucky Stroke Study. Stroke. 2010;41:1326–31. doi: 10.1161/STROKEAHA.109.575043.
    1. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123:933–44. doi: 10.1161/CIR.0b013e31820a55f5.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere